{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_stdName in Standardized Name (approximate match)
Status:
US Previously Marketed
Source:
Amevive
(2003)
Source URL:
First approved in 2003
Source:
Amevive
Source URL:
Class:
PROTEIN
Status:
US Previously Marketed
Source:
MYOSCINT by CENTOCOR INC
(1996)
Source URL:
First approved in 1996
Source:
MYOSCINT by CENTOCOR INC
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M009
(2025)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01107756: Phase 4 Interventional Completed Neoplasms (no Otherwise Specified)
(2010)
Source URL:
Class:
PROTEIN